Toronto Dominion Bank’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-2,840
Closed -$1K 1163
2015
Q3
$1K Buy
2,840
+188
+7% +$108 ﹤0.01% 1036
2015
Q2
$1K Buy
2,652
+186
+8% +$126 ﹤0.01% 1082
2015
Q1
$1K Buy
2,466
+466
+23% +$299 ﹤0.01% 1061
2014
Q4
$1K Hold
2,000
﹤0.01% 1028
2014
Q3
$0 Hold
2,000
﹤0.01% 1113
2014
Q2
$3K Hold
2,000
﹤0.01% 1034
2014
Q1
$4K Hold
2,000
﹤0.01% 1021
2013
Q4
$3K Hold
2,000
﹤0.01% 995
2013
Q3
$5K Sell
2,000
-100
-5% -$277 ﹤0.01% 731
2013
Q2
$6K Buy
+2,100
New +$5.81K ﹤0.01% 743

Other funds holding ONCY

Toronto Dominion Bank's ONCY Position: Q4 2015 in Review

Toronto Dominion Bank sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2015, closing a stake of 2,840 shares — an estimated $1K sold.

Toronto Dominion Bank first reported a position in ONCY in Q2 2013 and held it in 10 quarters. The position peaked at $6K in Q2 2013. 7 funds tracked by Wall St. Rank hold ONCY as of Q4 2015.

  • Toronto Dominion Bank reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2015 after selling out during the quarter.
  • Toronto Dominion Bank sold 2,840 ONCOLYTICS BIOTECH INC shares in Q4 2015, an estimated $1K.
  • Toronto Dominion Bank first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and held it in 10 quarters.
  • Toronto Dominion Bank's ONCOLYTICS BIOTECH INC position peaked at $6K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2015.

Based on Toronto Dominion Bank's 13F filing for Q4 2015, filed 9 Feb 2016.